MEIP – MEI Pharma Inc
Float Short %
32.59
Margin Of Safety %
Put/Call OI Ratio
0.17
EPS Next Q Diff
EPS Last/This Y
-2.67
EPS This/Next Y
Price
4.97
Target Price
22.67
Analyst Recom
2.33
Performance Q
125.91
Relative Volume
0.47
Beta
0.39
Ticker: MEIP
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-07-25 | MEIP | 6.74 | 0.22 | 0.25 | 8829 |
| 2025-07-28 | MEIP | 5.95 | 0.22 | 0.01 | 8806 |
| 2025-07-29 | MEIP | 5.04 | 0.22 | 0.27 | 8814 |
| 2025-07-30 | MEIP | 4.99 | 0.22 | 0.07 | 8887 |
| 2025-07-31 | MEIP | 5.1 | 0.22 | 0.11 | 8992 |
| 2025-08-01 | MEIP | 4.86 | 0.24 | 0.00 | 8812 |
| 2025-08-04 | MEIP | 5.12 | 0.24 | 0.01 | 8888 |
| 2025-08-05 | MEIP | 5.08 | 0.23 | 1.05 | 9129 |
| 2025-08-06 | MEIP | 4.97 | 0.24 | 0.41 | 9290 |
| 2025-08-07 | MEIP | 5.07 | 0.25 | 0.00 | 9437 |
| 2025-08-08 | MEIP | 5.21 | 0.25 | 0.05 | 9389 |
| 2025-08-11 | MEIP | 4.84 | 0.23 | 0.04 | 9867 |
| 2025-08-12 | MEIP | 4.86 | 0.23 | 0.03 | 10071 |
| 2025-08-13 | MEIP | 5.11 | 0.21 | 0.06 | 10945 |
| 2025-08-14 | MEIP | 4.9 | 0.20 | 0.39 | 11311 |
| 2025-08-15 | MEIP | 4.89 | 0.21 | 0.67 | 11864 |
| 2025-08-18 | MEIP | 4.88 | 0.16 | 0.21 | 8231 |
| 2025-08-19 | MEIP | 4.65 | 0.18 | 0.58 | 9397 |
| 2025-08-20 | MEIP | 4.64 | 0.20 | 0.05 | 9774 |
| 2025-08-21 | MEIP | 4.66 | 0.18 | 0.01 | 10837 |
| 2025-08-22 | MEIP | 4.98 | 0.17 | 0.70 | 11563 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-07-25 | MEIP | 6.74 | - | - | 0.00 |
| 2025-07-28 | MEIP | 5.95 | - | - | 0.00 |
| 2025-07-29 | MEIP | 5.05 | - | - | 0.00 |
| 2025-07-30 | MEIP | 5.05 | - | - | 0.00 |
| 2025-07-31 | MEIP | 5.15 | - | - | 0.00 |
| 2025-08-01 | MEIP | 4.87 | - | - | 0.00 |
| 2025-08-04 | MEIP | 5.12 | - | - | 0.00 |
| 2025-08-05 | MEIP | 5.05 | - | - | 0.00 |
| 2025-08-06 | MEIP | 4.97 | - | - | 0.00 |
| 2025-08-07 | MEIP | 5.10 | - | - | 0.00 |
| 2025-08-08 | MEIP | 5.19 | - | - | 0.00 |
| 2025-08-11 | MEIP | 4.86 | - | - | 0.00 |
| 2025-08-12 | MEIP | 4.85 | - | - | 0.00 |
| 2025-08-13 | MEIP | 5.14 | - | - | 0.00 |
| 2025-08-14 | MEIP | 4.89 | - | - | 0.00 |
| 2025-08-15 | MEIP | 4.89 | - | - | 0.00 |
| 2025-08-18 | MEIP | 4.86 | - | - | 0.00 |
| 2025-08-19 | MEIP | 4.68 | - | - | 0.00 |
| 2025-08-20 | MEIP | 4.59 | - | - | 0.00 |
| 2025-08-21 | MEIP | 4.62 | - | - | 0.00 |
| 2025-08-22 | MEIP | 4.97 | - | - | 0.00 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-07-25 | MEIP | 0.00 | -3.32 | 0.27 |
| 2025-07-28 | MEIP | 0.00 | -0.76 | 0.27 |
| 2025-07-29 | MEIP | 0.00 | -0.76 | 0.27 |
| 2025-07-30 | MEIP | 0.00 | -0.76 | 0.27 |
| 2025-07-31 | MEIP | 0.00 | -0.76 | 0.27 |
| 2025-08-01 | MEIP | 0.00 | -0.76 | 0.27 |
| 2025-08-04 | MEIP | 0.00 | -18.20 | 0.27 |
| 2025-08-05 | MEIP | 0.00 | -18.20 | 0.27 |
| 2025-08-06 | MEIP | 0.00 | -18.20 | 0.27 |
| 2025-08-07 | MEIP | 0.00 | -18.20 | 0.27 |
| 2025-08-08 | MEIP | 0.00 | -18.20 | 0.27 |
| 2025-08-11 | MEIP | 0.00 | -0.54 | 0.28 |
| 2025-08-12 | MEIP | 0.00 | -0.54 | 34.14 |
| 2025-08-13 | MEIP | 0.00 | -0.54 | 34.14 |
| 2025-08-14 | MEIP | 0.00 | -0.54 | 34.14 |
| 2025-08-15 | MEIP | 0.00 | -0.54 | 34.14 |
| 2025-08-18 | MEIP | 0.00 | -0.98 | 32.59 |
| 2025-08-19 | MEIP | 0.00 | -0.98 | 32.59 |
| 2025-08-20 | MEIP | 0.00 | -0.98 | 32.59 |
| 2025-08-21 | MEIP | 0.00 | -0.98 | 32.59 |
| 2025-08-22 | MEIP | 0.00 | -0.98 | 32.59 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
Avg. EPS Est. Next Quarter
Insider Transactions
Institutional Transactions
-0.98
Beta
0.39
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
6
Growth Score
Sentiment Score
43
Actual DrawDown %
94.6
Max Drawdown 5-Year %
-97.3
Target Price
22.67
P/E
Forward P/E
PEG
P/S
P/B
1.69
P/Free Cash Flow
EPS
-4.75
Average EPS Est. Cur. Y
EPS Next Y. (Est.)
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
0.47
Return on Equity vs Sector %
-186.7
Return on Equity vs Industry %
-173.8
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
MEI Pharma, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 28
MEI Pharma, Inc., a clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer. It develops ME-344, an intravenous small molecule inhibitor mitochondrial oxidative phosphorylation to treat human epidermal growth factor receptor 2 negative breast cancer, colorectal cancer, and solid tumors. The company was formerly known as Marshall Edwards, Inc. and changed its name to MEI Pharma, Inc. in July 2012. MEI Pharma, Inc. was incorporated in 2000 and is headquartered in San Diego, California.
stock quote shares MEIP – MEI Pharma Inc Stock Price stock today
news today MEIP – MEI Pharma Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch MEIP – MEI Pharma Inc yahoo finance google finance
stock history MEIP – MEI Pharma Inc invest stock market
stock prices MEIP premarket after hours
ticker MEIP fair value insiders trading